{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:12:09Z","timestamp":1790892729191,"version":"4.1.0"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1038\/s41423-020-0399-6","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T10:02:54Z","timestamp":1584612174000},"page":"335-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-4595","authenticated-orcid":false,"given":"Suqing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"key":"399_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nri.2016.101","volume":"16","author":"K Minton","year":"2016","unstructured":"Minton, K. Innate lymphoid cells: ILC diversity maintained by microbiota. Nat. Rev. Immunol. 16, 593 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"399_CR2","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ni.3489","volume":"17","author":"CS Klose","year":"2016","unstructured":"Klose, C. S. & Artis, D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat. Immunol. 17, 765\u2013774 (2016).","journal-title":"Nat. Immunol."},{"key":"399_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.chom.2012.10.003","volume":"12","author":"WE Tait","year":"2012","unstructured":"Tait, W. E. & Artis, D. Innate lymphoid cells: Balancing immunity, inflammation, and tissue repair in the intestine. Cell Host Microbe 12, 445\u2013457 (2012).","journal-title":"Cell Host Microbe"},{"key":"399_CR4","doi-asserted-by":"publisher","first-page":"101270","DOI":"10.1016\/j.smim.2019.03.002","volume":"41","author":"S Tugues","year":"2019","unstructured":"Tugues, S. et al. Innate lymphoid cells as regulators of the tumor microenvironment. Semin. Immunol. 41, 101270 (2019).","journal-title":"Semin. Immunol."},{"key":"399_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1146\/annurev-immunol-020711-075053","volume":"30","author":"H Spits","year":"2012","unstructured":"Spits, H. & Cupedo, T. Innate lymphoid cells: Emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30, 647\u2013675 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"399_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.immuni.2012.09.008","volume":"37","author":"N Powell","year":"2012","unstructured":"Powell, N. et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity 37, 674\u2013684 (2012).","journal-title":"Immunity"},{"key":"399_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","volume":"171","author":"OE Weizman","year":"2017","unstructured":"Weizman, O. E. et al. ILC1 confer early host protection at initial sites of viral infection. Cell 171, 795\u2013808 (2017).","journal-title":"Cell"},{"key":"399_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature14115","volume":"519","author":"JR Brestoff","year":"2015","unstructured":"Brestoff, J. R. et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519, 242\u2013246 (2015).","journal-title":"Nature"},{"key":"399_CR9","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ni.2133","volume":"12","author":"C Wilhelm","year":"2011","unstructured":"Wilhelm, C. et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 12, 1071\u20131077 (2011).","journal-title":"Nat. Immunol."},{"key":"399_CR10","doi-asserted-by":"publisher","first-page":"10762","DOI":"10.1073\/pnas.1509070112","volume":"112","author":"LA Monticelli","year":"2015","unstructured":"Monticelli, L. A. et al. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc. Natl Acad. Sci. USA 112, 10762\u201310767 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"399_CR11","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1073\/pnas.1201042109","volume":"109","author":"K Yasuda","year":"2012","unstructured":"Yasuda, K. et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc. Natl Acad. Sci. USA 109, 3451\u20133456 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"399_CR12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nature08900","volume":"464","author":"DR Neill","year":"2010","unstructured":"Neill, D. R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367\u20131370 (2010).","journal-title":"Nature"},{"key":"399_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature08636","volume":"463","author":"K Moro","year":"2010","unstructured":"Moro, K. et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463, 540\u2013544 (2010).","journal-title":"Nature"},{"key":"399_CR14","doi-asserted-by":"publisher","first-page":"11489","DOI":"10.1073\/pnas.1003988107","volume":"107","author":"AE Price","year":"2010","unstructured":"Price, A. E. et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl Acad. Sci. USA 107, 11489\u201311494 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"399_CR15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.immuni.2012.06.020","volume":"37","author":"T Hoyler","year":"2012","unstructured":"Hoyler, T. et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634\u2013648 (2012).","journal-title":"Immunity"},{"key":"399_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ni.2208","volume":"13","author":"SH Wong","year":"2012","unstructured":"Wong, S. H. et al. Transcription factor RORalpha is critical for nuocyte development. Nat. Immunol. 13, 229\u2013236 (2012).","journal-title":"Nat. Immunol."},{"key":"399_CR17","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/jid.2014.146","volume":"134","author":"M Teunissen","year":"2014","unstructured":"Teunissen, M. et al. Composition of innate lymphoid cell subsets in the human skin: Enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. J. Invest. Dermatol. 134, 2351\u20132360 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"399_CR18","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","volume":"74","author":"F Ciccia","year":"2015","unstructured":"Ciccia, F. et al. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann. Rheum. Dis. 74, 1739\u20131747 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"399_CR19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.immuni.2014.11.010","volume":"41","author":"E Montaldo","year":"2014","unstructured":"Montaldo, E. et al. Human RORgammat(+)CD34(+) cells are lineage-specified progenitors of group 3 RORgammat(+) innate lymphoid cells. Immunity 41, 988\u20131000 (2014).","journal-title":"Immunity"},{"key":"399_CR20","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054\u20131066 (2018).","journal-title":"Cell"},{"key":"399_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.imlet.2004.02.005","volume":"93","author":"H Tlaskalova-Hogenova","year":"2004","unstructured":"Tlaskalova-Hogenova, H. et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol. Lett. 93, 97\u2013108 (2004).","journal-title":"Immunol. Lett."},{"key":"399_CR22","first-page":"676","volume":"37","author":"M Hou","year":"2019","unstructured":"Hou, M. & Liu, S. Innate lymphoid cells are increased in systemic lupus erythematosus. Clin. Exp. Rheumatol. 37, 676\u2013679 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"399_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/ni.2584","volume":"14","author":"B Roediger","year":"2013","unstructured":"Roediger, B. et al. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat. Immunol. 14, 564\u2013573 (2013).","journal-title":"Nat. Immunol."},{"key":"399_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits, H. et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145\u2013149 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"399_CR25","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.cell.2016.07.043","volume":"166","author":"M Gury-BenAri","year":"2016","unstructured":"Gury-BenAri, M. et al. The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome. Cell 166, 1231\u20131246 (2016).","journal-title":"Cell"},{"key":"399_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/eji.1830050208","volume":"5","author":"R Kiessling","year":"1975","unstructured":"Kiessling, R. et al. \u201cNatural\u201d killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5, 112\u2013117 (1975).","journal-title":"Eur. J. Immunol."},{"key":"399_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1074-7613(00)80371-4","volume":"7","author":"RE Mebius","year":"1997","unstructured":"Mebius, R. E. et al. Developing lymph nodes collect CD4+ CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7, 493\u2013504 (1997).","journal-title":"Immunity"},{"key":"399_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature11885","volume":"495","author":"L Ding","year":"2013","unstructured":"Ding, L. & Morrison, S. J. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 495, 231\u2013235 (2013).","journal-title":"Nature"},{"key":"399_CR29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","volume":"157","author":"C Klose","year":"2014","unstructured":"Klose, C. et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157, 340\u2013356\u00a0(2014).","journal-title":"Cell"},{"key":"399_CR30","first-page":"1105","volume":"203","author":"S Carotta","year":"2011","unstructured":"Carotta, S. et al. Identification of the earliest NK-cell precursor in the mouse BM. J. Exp. Med. 203, 1105\u20131116\u00a0(2011).","journal-title":"J. Exp. Med."},{"key":"399_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature13047","volume":"508","author":"M. G. Constantinides","year":"2014","unstructured":"Constantinides, M. G. et al. A committed precursor to innate lymphoid cells. Nature 508, 397\u2013401\u00a0(2014).","journal-title":"Nature"},{"key":"399_CR32","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1242\/dev.037317","volume":"136","author":"E. L. Rawlins","year":"2009","unstructured":"Rawlins, E. L. et al. The Id2+ distal tip lung epithelium contains individual multipotent embryonic progenitor cells. Development 136, 3741\u20133745\u00a0(2009).","journal-title":"Development"},{"key":"399_CR33","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1084\/jem.20061959","volume":"204","author":"M. D. Boos","year":"2007","unstructured":"Boos, M. D. et al. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 204, 1119\u20131130\u00a0(2007).","journal-title":"J. Exp. Med."},{"key":"399_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1084\/jem.20131560","volume":"211","author":"C Daussy","year":"2014","unstructured":"Daussy, C. et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J. Exp. Med. 211, 563\u2013577\u00a0(2014).","journal-title":"J. Exp. Med."},{"key":"399_CR35","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","volume":"37","author":"J Mjosberg","year":"2012","unstructured":"Mjosberg, J. et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37, 649\u2013659\u00a0(2012).","journal-title":"Immunity"},{"key":"399_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ni.1681","volume":"10","author":"C Luci","year":"2009","unstructured":"Luci, C. et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin.\u00a0Nat. Immunol. 10, 75\u201382\u00a0(2009).","journal-title":"Nat. Immunol."},{"key":"399_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaut.2015.08.011","volume":"66","author":"K Hudspeth","year":"2016","unstructured":"Hudspeth, K. et al. Human liver-resident CD56(bright)\/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. J. Autoimmun. 66, 40\u201350 (2016).","journal-title":"J. Autoimmun."},{"key":"399_CR38","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1002\/eji.201141445","volume":"41","author":"V Male","year":"2011","unstructured":"Male, V. et al. The effect of pregnancy on the uterine NK cell KIR repertoire. Eur. J. Immunol. 41, 3017\u20133027 (2011).","journal-title":"Eur. J. Immunol."},{"key":"399_CR39","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jaci.2016.07.043","volume":"139","author":"N Marquardt","year":"2017","unstructured":"Marquardt, N. et al. Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69(-)CD56(dim) cells. J. Allergy Clin. Immunol. 139, 1321\u20131330 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"399_CR40","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1182\/blood-2012-10-459545","volume":"121","author":"V Beziat","year":"2013","unstructured":"Beziat, V. et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121, 2678\u20132688 (2013).","journal-title":"Blood"},{"key":"399_CR41","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.gastro.2012.10.039","volume":"144","author":"F Li","year":"2013","unstructured":"Li, F. et al. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice. Gastroenterology 144, 392\u2013401 (2013).","journal-title":"Gastroenterology"},{"key":"399_CR42","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","volume":"42","author":"H Schlums","year":"2015","unstructured":"Schlums, H. et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 42, 443\u2013456 (2015).","journal-title":"Immunity"},{"key":"399_CR43","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/cmi.2015.42","volume":"13","author":"T Krneta","year":"2016","unstructured":"Krneta, T. et al. The breast tumor microenvironment alters the phenotype and function of natural killer cells. Cell. Mol. Immunol. 13, 628\u2013639 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"399_CR44","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/s41590-019-0511-1","volume":"20","author":"X Zheng","year":"2019","unstructured":"Zheng, X. et al. Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance. Nat. Immunol. 20, 1656\u20131667 (2019).","journal-title":"Nat. Immunol."},{"key":"399_CR45","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cell.2018.12.022","volume":"176","author":"AJ Davies","year":"2019","unstructured":"Davies, A. J. et al. Natural killer cells degenerate intact sensory afferents following nerve injury. Cell 176, 716\u2013728 (2019).","journal-title":"Cell"},{"key":"399_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cell.2017.03.002","volume":"169","author":"OA Aguilar","year":"2017","unstructured":"Aguilar, O. A. et al. A viral immunoevasin controls innate immunity by targeting the prototypical natural killer cell receptor family. Cell 169, 58\u201371 (2017).","journal-title":"Cell"},{"key":"399_CR47","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP Bottcher","year":"2018","unstructured":"Bottcher, J. P. et al. NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell 172, 1022\u20131037 (2018).","journal-title":"Cell"},{"key":"399_CR48","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cell.2019.04.041","volume":"177","author":"L Gauthier","year":"2019","unstructured":"Gauthier, L. et al. Multifunctional natural killer cell engagers targeting NKp46 trigger protective tumor immunity. Cell 177, 1701\u20131713 (2019).","journal-title":"Cell"},{"key":"399_CR49","doi-asserted-by":"publisher","unstructured":"Anft, M. et al. NK cell detachment from target cells is regulated by successful cytotoxicity and influences cytokine production. Cell. Mol. Immunol. https:\/\/doi.org\/10.1038\/s41423-019-0277-2 (2019).","DOI":"10.1038\/s41423-019-0277-2"},{"key":"399_CR50","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni.2534","volume":"14","author":"JH Bernink","year":"2013","unstructured":"Bernink, J. H. et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14, 221\u2013229 (2013).","journal-title":"Nat. Immunol."},{"key":"399_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/cmi.2012.8","volume":"9","author":"X Jiang","year":"2012","unstructured":"Jiang, X. et al. Single line or parallel lines: NK cell differentiation driven by T-bet and Eomes. Cell. Mol. Immunol. 9, 193\u2013194 (2012).","journal-title":"Cell. Mol. Immunol."},{"key":"399_CR52","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1073\/pnas.1423244112","volume":"112","author":"MG Constantinides","year":"2015","unstructured":"Constantinides, M. G. et al. PLZF expression maps the early stages of ILC1 lineage development. Proc. Natl Acad. Sci. USA 112, 5123\u20135128 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"399_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07405-5","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Memory formation and long-term maintenance of IL-7Ralpha(+) ILC1s via a lymph node-liver axis. Nat. Commun. 9, 4854 (2018).","journal-title":"Nat. Commun."},{"key":"399_CR54","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","volume":"15","author":"MM Fort","year":"2001","unstructured":"Fort, M. M. et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985\u2013995 (2001).","journal-title":"Immunity"},{"key":"399_CR55","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1084\/jem.20051615","volume":"203","author":"PG Fallon","year":"2006","unstructured":"Fallon, P. G. et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203, 1105\u20131116 (2006).","journal-title":"J. Exp. Med"},{"key":"399_CR56","doi-asserted-by":"crossref","unstructured":"Price, A. E. et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity (2010).","DOI":"10.1073\/pnas.1003988107"},{"key":"399_CR57","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.it.2012.07.006","volume":"33","author":"L Guo","year":"2012","unstructured":"Guo, L. et al. Cytokine-induced cytokine production by conventional and innate lymphoid cells. Trends Immunol. 33, 598\u2013606 (2012).","journal-title":"Trends Immunol."},{"key":"399_CR58","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaci.2013.03.048","volume":"132","author":"TA Doherty","year":"2013","unstructured":"Doherty, T. A. et al. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J. Allergy Clin. Immunol. 132, 205\u2013213 (2013).","journal-title":"J. Allergy Clin. Immunol"},{"key":"399_CR59","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ni.3447","volume":"17","author":"Y Ohne","year":"2016","unstructured":"Ohne, Y. et al. IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. Nat. Immunol. 17, 646\u2013655 (2016).","journal-title":"Nat. Immunol."},{"key":"399_CR60","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jaci.2016.02.030","volume":"138","author":"RM Noval","year":"2016","unstructured":"Noval, R. M. et al. IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function. J. Allergy Clin. Immunol. 138, 801\u2013811 (2016).","journal-title":"J. Allergy Clin. Immunol"},{"key":"399_CR61","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/ni.3444","volume":"17","author":"SM Bal","year":"2016","unstructured":"Bal, S. M. et al. IL-1beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat. Immunol. 17, 636\u2013645 (2016).","journal-title":"Nat. Immunol."},{"key":"399_CR62","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/cmi.2016.63","volume":"15","author":"Z Tan","year":"2018","unstructured":"Tan, Z. et al. Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells. Cell. Mol. Immunol. 15, 388\u2013398 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"399_CR63","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature16161","volume":"529","author":"J von Moltke","year":"2016","unstructured":"von Moltke, J. et al. Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature 529, 221\u2013225 (2016).","journal-title":"Nature"},{"key":"399_CR64","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2018.05.014","volume":"174","author":"C Schneider","year":"2018","unstructured":"Schneider, C. et al. A Metabolite-Triggered tuft Cell-ILC2 circuit drives small intestinal remodeling. Cell 174, 271\u2013284 (2018).","journal-title":"Cell"},{"key":"399_CR65","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature24029","volume":"549","author":"A Wallrapp","year":"2017","unstructured":"Wallrapp, A. et al. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature 549, 351\u2013356 (2017).","journal-title":"Nature"},{"key":"399_CR66","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.aan4829","volume":"359","author":"S Moriyama","year":"2018","unstructured":"Moriyama, S. et al. Beta2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses. Science 359, 1056\u20131061 (2018).","journal-title":"Science"},{"key":"399_CR67","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature23469","volume":"549","author":"V Cardoso","year":"2017","unstructured":"Cardoso, V. et al. Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. Nature 549, 277\u2013281 (2017).","journal-title":"Nature"},{"key":"399_CR68","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature14115","volume":"519","author":"JR Brestoff","year":"2015","unstructured":"Brestoff, J. R. et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519, 242\u2013246 (2015).","journal-title":"Nature"},{"key":"399_CR69","doi-asserted-by":"publisher","first-page":"10132","DOI":"10.1073\/pnas.97.18.10132","volume":"97","author":"S Kurebayashi","year":"2000","unstructured":"Kurebayashi, S. et al. Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc. Natl Acad. Sci. USA 97, 10132\u201310137 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"399_CR70","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ni.1668","volume":"10","author":"T Cupedo","year":"2009","unstructured":"Cupedo, T. et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC\u2009+\u2009CD127+ natural killer-like cells. Nat. Immunol. 10, 66\u201374 (2009).","journal-title":"Nat. Immunol."},{"key":"399_CR71","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nature07537","volume":"457","author":"M Cella","year":"2009","unstructured":"Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722\u2013725 (2009).","journal-title":"Nature"},{"key":"399_CR72","doi-asserted-by":"publisher","unstructured":"Wang, Q. et al. Circadian rhythm-dependent and circadian rhythm-independent impacts of the molecular clock on type 3 innate lymphoid cells. Sci. Immunol. 4, eaay7501, https:\/\/doi.org\/10.1126\/sciimmunol.aay7501 (2019).","DOI":"10.1126\/sciimmunol.aay7501"},{"key":"399_CR73","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41590-019-0423-0","volume":"20","author":"JH Bernink","year":"2019","unstructured":"Bernink, J. H. et al. C-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies. Nat. Immunol. 20, 992\u20131003 (2019).","journal-title":"Nat. Immunol."},{"key":"399_CR74","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.smim.2011.01.008","volume":"23","author":"B Stockinger","year":"2011","unstructured":"Stockinger, B. et al. External influences on the immune system via activation of the aryl hydrocarbon receptor. Semin. Immunol. 23, 99\u2013105 (2011).","journal-title":"Semin. Immunol."},{"key":"399_CR75","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2011.11.011","volume":"36","author":"J Qiu","year":"2012","unstructured":"Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92\u2013104 (2012).","journal-title":"Immunity"},{"key":"399_CR76","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.immuni.2018.09.015","volume":"49","author":"S Li","year":"2018","unstructured":"Li, S. et al. Aryl hydrocarbon receptor signaling cell intrinsically inhibits intestinal group 2 innate lymphoid cell function. Immunity 49, 915\u2013928 (2018).","journal-title":"Immunity"},{"key":"399_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9280","volume":"6","author":"P Carrega","year":"2015","unstructured":"Carrega, P. et al. NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nat. Commun. 6, 8280 (2015).","journal-title":"Nat. Commun."},{"key":"399_CR78","doi-asserted-by":"publisher","first-page":"1254009","DOI":"10.1126\/science.1254009","volume":"345","author":"Y Goto","year":"2014","unstructured":"Goto, Y. et al. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 345, 1254009 (2014).","journal-title":"Science"},{"key":"399_CR79","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41423-018-0169-x","volume":"16","author":"E Abou-Samra","year":"2019","unstructured":"Abou-Samra, E. et al. NKR-P1B expression in gut-associated innate lymphoid cells is required for the control of gastrointestinal tract infections. Cell. Mol. Immunol. 16, 868\u2013877 (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"399_CR80","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nature18644","volume":"535","author":"S Ibiza","year":"2016","unstructured":"Ibiza, S. et al. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature 535, 440\u2013443 (2016).","journal-title":"Nature"},{"key":"399_CR81","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41586-019-1579-3","volume":"574","author":"C Godinho-Silva","year":"2019","unstructured":"Godinho-Silva, C. et al. Light-entrained and brain-tuned circadian circuits regulate ILC3s and gut homeostasis. Nature 574, 254\u2013258 (2019).","journal-title":"Nature"},{"key":"399_CR82","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2016.12.009","volume":"46","author":"J Dalli","year":"2017","unstructured":"Dalli, J. et al. Vagal regulation of group 3 innate lymphoid cells and the immunoresolvent PCTR1 controls infection resolution. Immunity 46, 92\u2013105 (2017).","journal-title":"Immunity"},{"key":"399_CR83","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.aaa4812","volume":"348","author":"MR Hepworth","year":"2015","unstructured":"Hepworth, M. R. et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells. Science 348, 1031\u20131035 (2015).","journal-title":"Science"},{"key":"399_CR84","doi-asserted-by":"publisher","unstructured":"Orlik, C. et al. Keratinocytes costimulate naive human T cells via CD2: A potential target to prevent the development of proinflammatory Th1 cells in the skin. Cell. Mol. Immunol. https:\/\/doi.org\/10.1038\/s41423-019-0261-x (2019).","DOI":"10.1038\/s41423-019-0261-x"},{"key":"399_CR85","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri2622","volume":"9","author":"FO Nestle","year":"2009","unstructured":"Nestle, F. O. et al. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9, 679\u2013691 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"399_CR86","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-018-0084-5","volume":"19","author":"K Kabashima","year":"2019","unstructured":"Kabashima, K. et al. The immunological anatomy of the skin. Nat. Rev. Immunol. 19, 19\u201330 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"399_CR87","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1171700","volume":"324","author":"EA Grice","year":"2009","unstructured":"Grice, E. A. et al. Topographical and temporal diversity of the human skin microbiome. Science 324, 1190\u20131192 (2009).","journal-title":"Science"},{"key":"399_CR88","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.jid.2016.11.045","volume":"137","author":"RL Gallo","year":"2017","unstructured":"Gallo, R. L. Human skin is the largest epithelial surface for interaction with microbes. J. Invest. Dermatol. 137, 1213\u20131214 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"399_CR89","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.cell.2018.12.031","volume":"176","author":"T Kobayashi","year":"2019","unstructured":"Kobayashi, T. et al. Homeostatic control of sebaceous glands by innate lymphoid cells regulates commensal bacteria equilibrium. Cell 176, 982\u2013997 (2019).","journal-title":"Cell"},{"key":"399_CR90","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1111\/all.13801","volume":"74","author":"C Schwartz","year":"2019","unstructured":"Schwartz, C. et al. Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1beta. Allergy 74, 1920\u20131933 (2019).","journal-title":"Allergy"},{"key":"399_CR91","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.cell.2016.04.014","volume":"165","author":"OI Koues","year":"2016","unstructured":"Koues, O. I. et al. Distinct gene regulatory pathways for human innate versus adaptive lymphoid cells. Cell 165, 1134\u20131146 (2016).","journal-title":"Cell"},{"key":"399_CR92","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ng.2467","volume":"44","author":"LC Tsoi","year":"2012","unstructured":"Tsoi, L. C. et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44, 1341\u20131348 (2012).","journal-title":"Nat. Genet."},{"key":"399_CR93","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/ni.3272","volume":"16","author":"T Ebihara","year":"2015","unstructured":"Ebihara, T. et al. Runx3?specifies lineage commitment of innate lymphoid cells. Nat. Immunol. 16, 1124\u20131133 (2015).","journal-title":"Nat. Immunol."},{"key":"399_CR94","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.immuni.2012.01.005","volume":"36","author":"A Murthy","year":"2012","unstructured":"Murthy, A. et al. Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. Immunity 36, 105\u2013119 (2012).","journal-title":"Immunity"},{"key":"399_CR95","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1371\/journal.pbio.0060123","volume":"6","author":"S Demehri","year":"2008","unstructured":"Demehri, S. et al. Notch-deficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity. PLoS Biol. 6, e123 (2008).","journal-title":"PLoS Biol."},{"key":"399_CR96","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature10329","volume":"477","author":"MC Siracusa","year":"2011","unstructured":"Siracusa, M. C. et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 477, 229\u2013233 (2011).","journal-title":"Nature"},{"key":"399_CR97","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1084\/jem.20111594","volume":"209","author":"M Cherrier","year":"2012","unstructured":"Cherrier, M. et al. Notch, Id2, and RORgammat sequentially orchestrate the fetal development of lymphoid tissue inducer cells. J. Exp. Med. 209, 729\u2013740 (2012).","journal-title":"J. Exp. Med"},{"key":"399_CR98","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.4049\/jimmunol.1601421","volume":"198","author":"K Zhang","year":"2017","unstructured":"Zhang, K. et al. Cutting edge: Notch signaling promotes the plasticity of group-2 innate lymphoid cells. J. Immunol. 198, 1798\u20131803 (2017).","journal-title":"J. Immunol."},{"key":"399_CR99","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0140-6736(07)60279-7","volume":"369","author":"DP D\u2019Cruz","year":"2007","unstructured":"D\u2019Cruz, D. P. et al. Systemic lupus erythematosus. Lancet 369, 587\u2013596 (2007).","journal-title":"Lancet"},{"key":"399_CR100","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","volume":"393","author":"T Dorner","year":"2019","unstructured":"Dorner, T. & Furie, R. Novel paradigms in systemic lupus erythematosus. Lancet 393, 2344\u20132358 (2019).","journal-title":"Lancet"},{"key":"399_CR101","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.38628","volume":"66","author":"L Chiche","year":"2014","unstructured":"Chiche, L. et al. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol. 66, 1583\u20131595 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"399_CR102","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41423-018-0010-6","volume":"16","author":"M Liu","year":"2019","unstructured":"Liu, M. et al. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients. Cell. Mol. Immunol. 16, 367\u2013379 (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"399_CR103","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaut.2015.01.009","volume":"58","author":"NH Chang","year":"2015","unstructured":"Chang, N. H. et al. Interferon-alpha induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus. J. Autoimmun. 58, 100\u2013110 (2015).","journal-title":"J. Autoimmun."},{"key":"399_CR104","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/eji.201747303","volume":"48","author":"M Duster","year":"2018","unstructured":"Duster, M. et al. T cell-derived IFN-gamma downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus. Eur. J. Immunol. 48, 1364\u20131375 (2018).","journal-title":"Eur. J. Immunol."},{"key":"399_CR105","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clim.2019.03.008","volume":"202","author":"C Guo","year":"2019","unstructured":"Guo, C. et al. Innate lymphoid cell disturbance with increase in ILC1 in systemic lupus erythematosus. Clin. Immunol. 202, 49\u201358 (2019).","journal-title":"Clin. Immunol."},{"key":"399_CR106","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/rheumatology\/kez116","volume":"58","author":"S Blokland","year":"2019","unstructured":"Blokland, S. et al. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjogren\u2019s syndrome. Rheumatol. (Oxf.) 58, 1740\u20131745 (2019).","journal-title":"Rheumatol. (Oxf.)"},{"key":"399_CR107","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2567.2008.02887.x","volume":"126","author":"D Schepis","year":"2009","unstructured":"Schepis, D. et al. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology 126, 140\u2013146 (2009).","journal-title":"Immunology"},{"key":"399_CR108","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nri1901","volume":"6","author":"TA Waldmann","year":"2006","unstructured":"Waldmann, T. A. The biology of interleukin-2 and interleukin-15: Implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6, 595\u2013601 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"399_CR109","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","volume":"20","author":"A Arazi","year":"2019","unstructured":"Arazi, A. et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nat. Immunol. 20, 902\u2013914 (2019).","journal-title":"Nat. Immunol."},{"key":"399_CR110","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes, M. A. et al. Immunology of psoriasis. Annu. Rev. Immunol. 32, 227\u2013255 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"399_CR111","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1086\/503821","volume":"78","author":"RP Nair","year":"2006","unstructured":"Nair, R. P. et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am. J. Hum. Genet. 78, 827\u2013851 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"399_CR112","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000252565","volume":"140","author":"WC Tervaert","year":"1970","unstructured":"Tervaert, W. C. & Esseveld, H. A study of the incidence of haemolytic streptococci in the throat in patients with psoriasis vulgaris, with reference to their role in the pathogenesis of this disease. Dermatologica 140, 282\u2013290 (1970).","journal-title":"Dermatologica"},{"key":"399_CR113","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/annrheumdis-2016-209334","volume":"76","author":"SM Thorarensen","year":"2017","unstructured":"Thorarensen, S. M. et al. Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis. Ann. Rheum. Dis. 76, 521\u2013525 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"399_CR114","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/j.1365-2133.2008.08563.x","volume":"158","author":"YB Brauchli","year":"2008","unstructured":"Brauchli, Y. B. et al. Association between beta-blockers, other antihypertensive drugs and psoriasis: Population-based case-control study. Br. J. Dermatol. 158, 1299\u20131307 (2008).","journal-title":"Br. J. Dermatol"},{"key":"399_CR115","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/nm.3016","volume":"18","author":"B Becher","year":"2012","unstructured":"Becher, B. & Pantelyushin, S. Hiding under the skin: interleukin-17-producing gammadelta T cells go under the skin? Nat. Med 18, 1748\u20131750 (2012).","journal-title":"Nat. Med"},{"key":"399_CR116","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1172\/JCI61862","volume":"122","author":"S Pantelyushin","year":"2012","unstructured":"Pantelyushin, S. et al. Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 122, 2252\u20132256 (2012).","journal-title":"J. Clin. Invest."},{"key":"399_CR117","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov, I. I. et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121\u20131133 (2006).","journal-title":"Cell"},{"key":"399_CR118","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/jid.2013.477","volume":"134","author":"F Villanova","year":"2014","unstructured":"Villanova, F. et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J. Invest. Dermatol. 134, 984\u2013991 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"399_CR119","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","volume":"43","author":"JH Bernink","year":"2015","unstructured":"Bernink, J. H. et al. Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43, 146\u2013160 (2015).","journal-title":"Immunity"},{"key":"399_CR120","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ni.3078","volume":"16","author":"Y Huang","year":"2015","unstructured":"Huang, Y. et al. IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential \u2018inflammatory\u2019 type 2 innate lymphoid cells. Nat. Immunol. 16, 161\u2013169 (2015).","journal-title":"Nat. Immunol."},{"key":"399_CR121","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.jid.2016.07.017","volume":"136","author":"MC Bruggen","year":"2016","unstructured":"Bruggen, M. C. et al. In situ mapping of innate lymphoid cells in human skin: Evidence for remarkable differences between normal and inflamed skin. J. Invest. Dermatol. 136, 2396\u20132405 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"399_CR122","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/bjd.12658","volume":"170","author":"B Dyring-Andersen","year":"2014","unstructured":"Dyring-Andersen, B. et al. Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. Br. J. Dermatol. 170, 609\u2013616 (2014).","journal-title":"Br. J. Dermatol."},{"key":"399_CR123","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/ng.3424","volume":"47","author":"L Paternoster","year":"2015","unstructured":"Paternoster, L. et al. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat. Genet. 47, 1449\u20131456 (2015).","journal-title":"Nat. Genet."},{"key":"399_CR124","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ng1767","volume":"38","author":"CN Palmer","year":"2006","unstructured":"Palmer, C. N. et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38, 441\u2013446 (2006).","journal-title":"Nat. Genet."},{"key":"399_CR125","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jaci.2009.03.036","volume":"123","author":"E Rodriguez","year":"2009","unstructured":"Rodriguez, E. et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: Robust risk factors in atopic disease. J. Allergy Clin. Immunol. 123, 1361\u20131370 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"399_CR126","doi-asserted-by":"publisher","first-page":"116r","DOI":"10.1126\/scitranslmed.3005374","volume":"5","author":"BS Kim","year":"2013","unstructured":"Kim, B. S. et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci. Transl. Med. 5, 116r\u2013170r (2013).","journal-title":"Sci. Transl. Med."},{"key":"399_CR127","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jaci.2015.06.045","volume":"137","author":"SP Saunders","year":"2016","unstructured":"Saunders, S. P. et al. Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity. J. Allergy Clin. Immunol. 137, 482\u2013491 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"399_CR128","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jid.2016.12.011","volume":"137","author":"LY Chen","year":"2017","unstructured":"Chen, L. Y. et al. Protein palmitoylation by ZDHHC13 protects skin against microbial-driven dermatitis. J. Invest. Dermatol. 137, 894\u2013904 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"399_CR129","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41423-018-0182-0","volume":"16","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Kinetics of the accumulation of group 2 innate lymphoid cells in IL-33-induced and IL-25-induced murine models of asthma: a potential role for the chemokine CXCL16. Cell. Mol. Immunol. 16, 75\u201386 (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"399_CR130","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jaci.2013.05.012","volume":"132","author":"JL Barlow","year":"2013","unstructured":"Barlow, J. L. et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J. Allergy Clin. Immunol. 132, 933\u2013941 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"399_CR131","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1084\/jem.20130351","volume":"210","author":"M Salimi","year":"2013","unstructured":"Salimi, M. et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J. Exp. Med. 210, 2939\u20132950 (2013).","journal-title":"J. Exp. Med."},{"key":"399_CR132","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","volume":"133","author":"L Xue","year":"2014","unstructured":"Xue, L. et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J. Allergy Clin. Immunol. 133, 1184\u20131194 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"399_CR133","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.4049\/jimmunol.1401307","volume":"193","author":"BS Kim","year":"2014","unstructured":"Kim, B. S. et al. Basophils promote innate lymphoid cell responses in inflamed skin. J. Immunol. 193, 3717\u20133725 (2014).","journal-title":"J. Immunol."},{"key":"399_CR134","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jdermsci.2017.07.003","volume":"88","author":"S Mashiko","year":"2017","unstructured":"Mashiko, S. et al. Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis. J. Dermatol. Sci. 88, 167\u2013174 (2017).","journal-title":"J. Dermatol. Sci."},{"key":"399_CR135","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/cmi.2015.77","volume":"13","author":"D Jiao","year":"2016","unstructured":"Jiao, D. et al. NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation. Cell. Mol. Immunol. 13, 535\u2013550 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"399_CR136","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0091-6749(98)70248-9","volume":"101","author":"AM Irani","year":"1998","unstructured":"Irani, A. M. et al. Immunohistochemical detection of human basophils in late-phase skin reactions. J. Allergy Clin. Immunol. 101, 354\u2013362 (1998).","journal-title":"J. Allergy Clin. Immunol."},{"key":"399_CR137","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton, C. P. & Khanna, D. Systemic sclerosis. Lancet. 390, 1685\u20131699 (2017).","journal-title":"Lancet."},{"key":"399_CR138","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/1756-185X.12884","volume":"19","author":"C Foocharoen","year":"2016","unstructured":"Foocharoen, C. et al. Clinical characteristics of scleroderma overlap syndromes: Comparisons with pure scleroderma. Int. J. Rheum. Dis. 19, 913\u2013923 (2016).","journal-title":"Int. J. Rheum. Dis."},{"key":"399_CR139","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/1756-185X.13344","volume":"21","author":"R Rezaei","year":"2018","unstructured":"Rezaei, R. et al. Genetic implications in the pathogenesis of systemic sclerosis. Int. J. Rheum. Dis. 21, 1478\u20131486 (2018).","journal-title":"Int. J. Rheum. Dis."},{"key":"399_CR140","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1586\/1744666X.2016.1125782","volume":"12","author":"M De Martinis","year":"2016","unstructured":"De Martinis, M. et al. An overview of environmental risk factors in systemic sclerosis. Expert Rev. Clin. Immunol. 12, 465\u2013478 (2016).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"399_CR141","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3899\/jrheum.101144","volume":"38","author":"P Airo\u2019","year":"2011","unstructured":"Airo\u2019, P. et al. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies. J. Rheumatol. 38, 1329\u20131334 (2011).","journal-title":"J. Rheumatol."},{"key":"399_CR142","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.1246886","volume":"343","author":"CG Joseph","year":"2014","unstructured":"Joseph, C. G. et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 343, 152\u2013157 (2014).","journal-title":"Science"},{"key":"399_CR143","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.4049\/jimmunol.1501491","volume":"196","author":"F Roan","year":"2016","unstructured":"Roan, F. et al. CD4+ group 1 innate lymphoid cells (ILC) form a functionally distinct ILC subset that is increased in systemic sclerosis. J. Immunol. 196, 2051\u20132062 (2016).","journal-title":"J. Immunol."},{"key":"399_CR144","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1073\/pnas.0700021104","volume":"104","author":"AO Aliprantis","year":"2007","unstructured":"Aliprantis, A. O. et al. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc. Natl Acad. Sci. USA 104, 2827\u20132830 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"399_CR145","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/annrheumdis-2015-207388","volume":"75","author":"T Wohlfahrt","year":"2016","unstructured":"Wohlfahrt, T. et al. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis. Ann. Rheum. Dis. 75, 623\u2013626 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"399_CR146","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12016-012-8320-4","volume":"43","author":"TJ Cohen","year":"2012","unstructured":"Cohen, T. J. & Damoiseaux, J. Antineutrophil cytoplasmic autoantibodies: How are they detected and what is their use for diagnosis, classification and follow-up? Clin. Rev. Allergy Immunol. 43, 211\u2013219 (2012).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"399_CR147","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"Lyons, P. A. et al. Genetically distinct subsets within ANCA-associated vasculitis. N. Engl. J. Med. 367, 214\u2013223 (2012).","journal-title":"N. Engl. J. Med."},{"key":"399_CR148","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/art.40375","volume":"70","author":"CH Sunderkotter","year":"2018","unstructured":"Sunderkotter, C. H. et al. Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheumatol. 70, 171\u2013184 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"399_CR149","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2016.03.015","volume":"70","author":"C Braudeau","year":"2016","unstructured":"Braudeau, C. et al. Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis. J. Autoimmun. 70, 73\u201379 (2016).","journal-title":"J. Autoimmun."},{"key":"399_CR150","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/01.all.0000244794.03239.8e","volume":"6","author":"CM Mowad","year":"2006","unstructured":"Mowad, C. M. Patch testing: pitfalls and performance. Curr. Opin. Allergy Clin. Immunol. 6, 340\u2013344 (2006).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"399_CR151","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nri3150","volume":"12","author":"DH Kaplan","year":"2012","unstructured":"Kaplan, D. H. et al. Early immune events in the induction of allergic contact dermatitis. Nat. Rev. Immunol. 12, 114\u2013124 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"399_CR152","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/j.jid.2018.03.001","volume":"138","author":"DA Rafei-Shamsabadi","year":"2018","unstructured":"Rafei-Shamsabadi, D. A. et al. Lack of type 2 innate lymphoid cells promotes a type I-Driven enhanced immune response in contact hypersensitivity. J. Invest. Dermatol. 138, 1962\u20131972 (2018).","journal-title":"J. Invest. Dermatol."},{"key":"399_CR153","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jaci.2018.02.015","volume":"142","author":"A Keren","year":"2018","unstructured":"Keren, A. et al. Innate lymphoid cells 3 induce psoriasis in xenotransplanted healthy human skin. J. Allergy Clin. Immunol. 142, 305\u2013308 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"399_CR154","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4049\/jimmunol.1102224","volume":"188","author":"AB Van Belle","year":"2012","unstructured":"Van Belle, A. B. et al. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J. Immunol. 188, 462\u2013469 (2012).","journal-title":"J. Immunol."},{"key":"399_CR155","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jdermsci.2019.03.002","volume":"93","author":"C Imura","year":"2019","unstructured":"Imura, C. et al. A novel RORgammat inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations. J. Dermatol. Sci. 93, 176\u2013185 (2019).","journal-title":"J. Dermatol. Sci."},{"key":"399_CR156","unstructured":"Rompoti, N. et al. Real world data from a single Greek center on the use of secukinumab in plaque psoriasis: effectiveness, safety, drug survival, and identification of patients that sustain optimal response. J. Eur. Acad. Dermatol. Venereol. (2020)."},{"key":"399_CR157","doi-asserted-by":"publisher","unstructured":"Merola, J. F. et al. Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasis. J. Eur. Acad. Dermatol. Venereol. https:\/\/doi.org\/10.1111\/jdv.16181 (2020).","DOI":"10.1111\/jdv.16181"},{"key":"399_CR158","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/09546634.2017.1422591","volume":"29","author":"J Bilal","year":"2018","unstructured":"Bilal, J. et al. A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12\/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis. J. Dermatolog. Treat. 29, 569\u2013578 (2018).","journal-title":"J. Dermatolog. Treat"},{"key":"399_CR159","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.jid.2017.07.819","volume":"137","author":"J Dai","year":"2017","unstructured":"Dai, J. et al. Topical ROR inverse agonists suppress inflammation in mouse models of atopic dermatitis and acute irritant dermatitis. J. Invest. Dermatol. 137, 2523\u20132531 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"399_CR160","doi-asserted-by":"publisher","first-page":"13921","DOI":"10.1073\/pnas.1307321110","volume":"110","author":"Y Imai","year":"2013","unstructured":"Imai, Y. et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc. Natl Acad. Sci. USA 110, 13921\u201313926 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"399_CR161","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","volume":"60","author":"JM Oldhoff","year":"2005","unstructured":"Oldhoff, J. M. et al. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy 60, 693\u2013696 (2005).","journal-title":"Allergy"},{"key":"399_CR162","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","volume":"380","author":"ID Pavord","year":"2012","unstructured":"Pavord, I. D. et al. Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial. Lancet. 380, 651\u2013659 (2012).","journal-title":"Lancet."},{"key":"399_CR163","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","volume":"371","author":"HG Ortega","year":"2014","unstructured":"Ortega, H. G. et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N. Engl. J. Med. 371, 1198\u20131207 (2014).","journal-title":"N. Engl. J. Med."},{"key":"399_CR164","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fimmu.2017.00176","volume":"8","author":"LM Mora-Velandia","year":"2017","unstructured":"Mora-Velandia, L. M. et al. A human lin(-) CD123(+) CD127(low) population endowed with ILC features and migratory capabilities contributes to immunopathological hallmarks of psoriasis. Front Immunol. 8, 176 (2017).","journal-title":"Front Immunol."}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41423-020-0399-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-020-0399-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-020-0399-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:23:27Z","timestamp":1684617807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0399-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":164,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["399"],"URL":"https:\/\/doi.org\/10.1038\/s41423-020-0399-6","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,19]]},"assertion":[{"value":"1 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}